A NEW STRUCTURAL TRANSITION OF SERUM-ALBUMIN DEPENDENT ON THE STATE OF CYS34 - DETECTION BY H-1-NMR SPECTROSCOPY

被引:79
作者
CHRISTODOULOU, J [1 ]
SADLER, PJ [1 ]
TUCKER, A [1 ]
机构
[1] UNIV LONDON,BIRKBECK COLL,DEPT CHEM,CHRISTOPHER INGOLD LABS,LONDON WC1H 0PP,ENGLAND
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 1994年 / 225卷 / 01期
基金
英国惠康基金;
关键词
D O I
10.1111/j.1432-1033.1994.00363.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
1. Reactions of fatty-acid-free bovine serum albumin and recombinant human albumin with a range of antiarthritic gold(I) complexes [auranofin, deacetylated auranofin, triethylphosphinegold(I) chloride] and related thiols (thioglucose, tetraacetylthioglucose, glutathione, dithiothreitol) have been investigated using H-1-NMR spectroscopy. 2. In reactions of albumin with auranofin, tetraacetylthioglucose and dithiothreitol, release of cystine was detected, whereas for deacetylated auranofin, thioglucose and glutathione, mixed disulphides with cysteine were produced. It has been previously proposed that Cys34 of human and bovine serum albumins is partly blocked by disulphide formation with cysteine and glutathione. The above reactions lead to deblocking by thiol-disulphide interchange reactions. No release of glutathione from albumin was detected. 3. Changes in the His H epsilon 1 regions of the H-1-NMR spectra show that albumin exists in two structural forms dependent on whether the side-chain of Cys34 is a free thiolate, or blocked by gold(I)triethylphosphine, by disulphide formation with cysteine or by another form of oxidation. We propose that Cys34 is either in a buried or in an exposed environment; the possible molecular basis of the structural change is discussed. 4. The relationship between reactions at Cys34, cysteine release, and the observed structural transition are discussed in terms of chrysotherapy, albumin metabolism and the use of gold(I) as a heavy atom derivative in X-ray crystallographic studies of albumins.
引用
收藏
页码:363 / 368
页数:6
相关论文
共 18 条
  • [1] CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153
  • [2] 3-DIMENSIONAL STRUCTURE OF HUMAN-SERUM ALBUMIN
    CARTER, DC
    HE, XM
    MUNSON, SH
    TWIGG, PD
    GERNERT, KM
    BROOM, MB
    MILLER, TY
    [J]. SCIENCE, 1989, 244 (4909) : 1195 - 1198
  • [3] CARTER DC, 1992, NATURE, V358, P209
  • [4] COFFER MT, 1986, INORG CHEM, V25, P333
  • [5] THIOL COMPETITION FOR ET3PAUS-ALBUMIN - A NONENZYMATIC MECHANISM FOR ET3PO FORMATION
    COFFER, MT
    SHAW, CF
    HORMANN, AL
    MIRABELLI, CK
    CROOKE, ST
    [J]. JOURNAL OF INORGANIC BIOCHEMISTRY, 1987, 30 (03) : 177 - 187
  • [6] DHUBHGHAILL OM, 1992, J AM CHEM SOC, V114, P1117
  • [7] REACTIONS OF THE METALLODRUG AURANOFIN [(1-THIO-BETA-D-GLUCOPYRANOSE-2,3,4,6-TETRAACETATO-S)(TRIETHYLPHOSPHINE)GOLD] WITH BIOLOGICAL LIGANDS STUDIED BY RADIOISOTOPE METHODOLOGY
    ECKER, DJ
    HEMPEL, JC
    SUTTON, BM
    KIRSCH, R
    CROOKE, ST
    [J]. INORGANIC CHEMISTRY, 1986, 25 (18) : 3139 - 3143
  • [8] TISSUE SULFHYDRYL GROUPS
    ELLMAN, GL
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1959, 82 (01) : 70 - 77
  • [9] AURANOFIN - NEW ORAL GOLD COMPOUND FOR TREATMENT OF RHEUMATOID-ARTHRITIS
    FINKELSTEIN, AE
    WALZ, DT
    BATISTA, V
    MIZRAJI, M
    ROISMAN, F
    MISHER, A
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1976, 35 (03) : 251 - 257
  • [10] FRANGLEN G, 1974, STRUCTURE FUNCTION P, V1, P265